Merck to Pay $625M Plus Royalties in BMS Lawsuit

Bristol-Myers Squibb and partner Ono Pharmaceutical settle with Merck on patent-infringement battle for anti-PD-1 therapy Keytruda
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news